How effective is cycloserine in treating tuberculosis? Does it need to be used in combination with other drugs?

Cycloserine (Cycloserine) is a broad-spectrum antibiotic that is a second-line anti-tuberculosis drug and is mainly used to treat drug-resistant tuberculosis, especially when conventional drug treatment fails. Its main mechanism of action is to interfere with the activity of tuberculosis branch secreted acyltransferase by inhibiting key enzymes in bacterial cell wall synthesis, thereby inhibiting the growth of tuberculosis branches. Cycloserine has good antibacterial activity against Mycobacterium tuberculosis (Mycobacterium tuberculosis), and is especially important in the treatment of drug-resistant tuberculosis strains.

In the treatment of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), cycloserine is often used as an auxiliary drug. Its efficacy as a single treatment is relatively poor and it is usually not used as a first-line drug. Combined with clinical data, cycloserine can effectively help control the progression of drug-resistant tuberculosis, especially when used in combination with other anti-tuberculosis drugs. Cycloserine plays an important complementary role in the treatment of pulmonary tuberculosis, especially drug-resistant strains of tuberculosis that are refractory to conventional treatments.

The importance of combining medications

Cycloserine is not used alone in the treatment of tuberculosis, but must be used in combination with other anti-tuberculosis drugs. This is because a single drug often leads to resistance, especially when Mycobacterium tuberculosis becomes resistant to multiple commonly used drugs. Therefore, cycloserine is often used together with other anti-tuberculosis drugs (such as rifampicin, isoniazid, aminoglycosides, etc.) to increase efficacy and reduce the risk of drug resistance. Combining drugs not only enhances the therapeutic effect, but also effectively prevents the resistance of M. tuberculosis to a single drug.

Combination drug strategies are usually formulated based on the drug resistance spectrum and specific conditions of TB patients. Especially when dealing with MDR-TB and XDR-TB, the treatment plan needs to be personalized based on drug sensitivity test results. The application of cycloserine in patients with multidrug-resistant tuberculosis (MDR-TB) generally needs to last for a long time, and the treatment plan usually includes at least 4 different drugs to ensure efficacy and reduce possible drug resistance during treatment.

Side effects and precautions for use

Although cycloserine plays an important role in the treatment of tuberculosis, its side effects cannot be ignored. The most common side effects include central nervous system reactions such as dizziness, drowsiness, mental status changes (such as depression, anxiety), and symptoms of dementia. These side effects are often associated with high doses and long-term use, so patients' neurological symptoms require special attention when using cycloserine. In addition, cycloserine may cause allergic reactions, liver damage, and kidney dysfunction. In order to reduce these adverse reactions, patients need to undergo regular blood tests, liver and kidney function tests, and neurological evaluations during treatment.

In order to reduce the occurrence of central nervous system side effects, doctors usually adjust the dosage of cycloserine according to the patient's specific conditions, and may use it in combination with other drugs (such as benzodiazepines) as needed to alleviate adverse effects on the nervous system. In addition, during the treatment process, it is also necessary to ensure that the patient receives adequate nutrition and rest to enhance physical strength and improve the ability to resist drug resistance.

In general, cycloserine has an irreplaceable role in the treatment of pulmonary tuberculosis, especially drug-resistant tuberculosis (such asMDR-TB and XDR-TB). As a second-line drug, when used in combination with other anti-tuberculosis drugs, it can effectively control the growth of drug-resistant strains and increase the chance of treatment success. However, due to its potential side effects, the patient's physical response needs to be carefully monitored when using cycloserine and the treatment regimen adjusted to minimize the risk of adverse effects. The use of cycloserine must be under the guidance of a professional doctor, and the dose must be adjusted according to the patient's individual needs to ensure safety and efficacy.

Reference materials:https://en.wikipedia.org/wiki/Cycloserine